不同输注速率的瑞马唑仑在全身麻醉诱导时的有效性及安全性研究

Effectiveness and safety of different infusion rates of remimazolam during induction of general anesthesia

  • 摘要:
    目的 探讨全身麻醉诱导时不同输注速率瑞马唑仑对麻醉诱导的效果及安全性。
    方法 选择全麻下行择期妇科手术患者80例为研究对象,随机分为A组静脉泵注瑞马唑仑诱导麻醉3 mg/(kg·h), B组静脉泵注瑞马唑仑诱导麻醉6 mg/(kg·h), 每组40例。待患者意识消失后依次给予顺苯磺酸阿曲库铵、舒芬太尼后气管插管,随后泵注瑞马唑仑和瑞芬太尼维持麻醉,保持脑电双频指数(BIS值)40~60。分别记录患者诱导前(T0)、意识消失时(T1)、插管前(T2)、插管后1 min(T3)、插管后5 min(T4)患者收缩压(SBP)、心率(HR)、BIS值的变化; 比较诱导剂量、意识消失时间(LoC)、诱导成功率、注射部位痛病例数、诱导期呃逆病例数,麻醉诱导期间低血压、高血压及心动过缓病例数以及苏醒时间。
    结果 与T0时相比, T1~T4时2组患者SBP及BIS值均降低,且T2及T4时2组患者HR均降低,差异有统计学意义(P < 0.05); 2组患者各时点SBP、HR、BIS值、低血压、高血压、心动过缓及注射部位痛发生率比较,差异无统计学意义(P>0.05); A组LoC稍有延长,但A组诱导用药量减少,诱导期间的呃逆发生率降低,差异有统计学意义(P < 0.05)。
    结论 静脉泵注瑞马唑仑诱导麻醉3 mg/(kg·h)在全麻诱导时更加安全有效。

     

    Abstract:
    Objective To investigate the effect and safety of different infusion rates of remimazolam in induction of general anesthesia.
    Methods Eighty patients undergoing elective gynecological surgery under general anesthesia were selected, and were randomly divided into group A given intravenous infusion of remazolam for 3 mg/(kg·h) to induce anesthesia and group B receiving intravenous infusion of remazolam for 6 mg/(kg·h) to induce anesthesia, with 40 cases per group. After consciousness disappeared, patients were given endotracheal intubation after successively infusion of cisatracurium besilate and sufentanil, followed by pump injection of remazolam and remifentanil to maintain anesthesia, and bispectral index (BIS) value of 40 to 60 were maintained. The changes of systolic blood pressure (SBP), heart rate (HR) and BIS were recorded before induction (T0), at the time of consciousness disappearance (T1), before intubation (T2), 1 min after intubation (T3), and 5 min after intubation (T4); induction dose, time of loss of consciousness (LoC), induction success rate, the number of pain cases at the injection site, the number of hiccup cases, the number of hypotension, hypertension and bradycardia cases during induction and awakening time were recorded.
    Results Compared with T0, the SBP and BIS values of patients in both groups at T1 to T4 were significantly lower, and the values of HR in both groups at T2 and T4 were significantly lower (P < 0.05); there were no significant differences in SBP, HR, BIS value and the incidence of hypotension, hypertension, bradycardia and pain of injection site between the group A and group B at each time point (P>0.05). In group A, the time of LoC was slightly prolonged, but the induction dose was reduced, the incidence of hiccup during induction was decreased(P < 0.05).
    Conclusion Remimazolam at infusion rate of 3 mg/(kg·h) is safer and more effective during induction of general anesthesia.

     

/

返回文章
返回